CLINICAL_TRIALS ClinicalTrials.gov record update

The LATENT Trial: Lytic Activation To Enhance Neoantigen-directed Therapy A Study to Evaluate the Feasibility and Efficacy of the Combined Use of Avelumab With Valproic Acid for the Treatment of Virus-associated Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03357757
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:39.266200+00:00
Published At: 2025-06-26T00:00:00+00:00
Record Updated At: 2025-06-26
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Cancer That is Associated With a Chronic Viral Infection", "p16 Positive SCCHN", "Squamous Cell Carcinoma of the Cervix", "p16 Positive Squamous Cell Carcinoma of the Vagina or Vulva", "p16 Positive Squamous Cell Carcinoma of the Penis", "p16 Positive Squamous Cell Carcinoma of the Anus or Anal Canal", "EBER Positive NPC", "EBER Positive Hodgkins and Non-hodgkins Lymphona"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-06-26"
protocolSection.identificationModule.nctId: "NCT03357757"
protocolSection.identificationModule.officialTitle: "The LATENT Trial: Lytic Activation To Enhance Neoantigen-directed Therapy A Study to Evaluate the Feasibility and Efficacy of the Combined Use of Avelumab With Valproic Acid for the Treatment of Virus-associated Cancer"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.